The data suggest that, if triglyceride lowering is achieved via improved TRL clearance, apoC-III deficiency enhances insulin signaling and therewith might resolve ER stress, resulting in smaller necrotic cores. The gene discussed is APOC3; the disease is hyperinsulinemic hypoglycemia, familial, 4.